AFM28 induced a significant reduction of CD123+ LSPCs, resulting in 98% (range 95–99%) depletion of the LSPC population in both AML (n = 5) and HR-MDS (n = 5) (Fig. 3B, C). The gene discussed is IL3RA; the disease is acute myeloid leukemia.